Addex Therapeutics (Switzerland) Probability of Future Stock Price Finishing Over 0.28

ADXN Stock  CHF 0.06  0.0008  1.27%   
Addex Therapeutics' future price is the expected price of Addex Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Addex Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Addex Therapeutics Backtesting, Addex Therapeutics Valuation, Addex Therapeutics Correlation, Addex Therapeutics Hype Analysis, Addex Therapeutics Volatility, Addex Therapeutics History as well as Addex Therapeutics Performance.
For more information on how to buy Addex Stock please use our How to Invest in Addex Therapeutics guide.
  
Please specify Addex Therapeutics' target price for which you would like Addex Therapeutics odds to be computed.

Addex Therapeutics Target Price Odds to finish over 0.28

The tendency of Addex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over ₣ 0.28  or more in 90 days
 0.06 90 days 0.28 
close to zero percent
Based on a normal probability distribution, the odds of Addex Therapeutics to move over ₣ 0.28  or more in 90 days from now is close to zero percent (This Addex Therapeutics probability density function shows the probability of Addex Stock to fall within a particular range of prices over 90 days) . Probability of Addex Therapeutics price to stay between its current price of ₣ 0.06  and ₣ 0.28  at the end of the 90-day period is about 89.96 .
Assuming the 90 days trading horizon Addex Therapeutics has a beta of 0.0532. This suggests as returns on the market go up, Addex Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Addex Therapeutics will be expected to be much smaller as well. Additionally Addex Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Addex Therapeutics Price Density   
       Price  

Predictive Modules for Addex Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Addex Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.065.45
Details
Intrinsic
Valuation
LowRealHigh
0.000.065.45
Details
Naive
Forecast
LowNextHigh
00.075.46
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.050.060.06
Details

Addex Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Addex Therapeutics is not an exception. The market had few large corrections towards the Addex Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Addex Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Addex Therapeutics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.22
β
Beta against Dow Jones0.05
σ
Overall volatility
0.01
Ir
Information ratio -0.06

Addex Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Addex Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Addex Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Addex Therapeutics generated a negative expected return over the last 90 days
Addex Therapeutics has high historical volatility and very poor performance
Addex Therapeutics has some characteristics of a very speculative penny stock
The company reported the revenue of 2.92 M. Net Loss for the year was (15.35 M) with loss before overhead, payroll, taxes, and interest of (9.69 M).
Addex Therapeutics has accumulated about 20.48 M in cash with (14.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Addex Therapeutics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Addex Stock often depends not only on the future outlook of the current and potential Addex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Addex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.1 M
Cash And Short Term Investments20.5 M

Addex Therapeutics Technical Analysis

Addex Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Addex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Addex Therapeutics. In general, you should focus on analyzing Addex Stock price patterns and their correlations with different microeconomic environments and drivers.

Addex Therapeutics Predictive Forecast Models

Addex Therapeutics' time-series forecasting models is one of many Addex Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Addex Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Addex Therapeutics

Checking the ongoing alerts about Addex Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Addex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Addex Therapeutics generated a negative expected return over the last 90 days
Addex Therapeutics has high historical volatility and very poor performance
Addex Therapeutics has some characteristics of a very speculative penny stock
The company reported the revenue of 2.92 M. Net Loss for the year was (15.35 M) with loss before overhead, payroll, taxes, and interest of (9.69 M).
Addex Therapeutics has accumulated about 20.48 M in cash with (14.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Additional Tools for Addex Stock Analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.